Literature DB >> 31825111

Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.

Miyoung Kim1, Young Kyung Lee1, Bumjung Park2, Dong Jun Oh3, Hyo Geun Choi2,4.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are suspected of being associated with non-Hodgkin lymphoma (NHL); however, persuasive data are lacking. Hence, a nested large-population case-control study was performed to investigate such associations in Koreans.
METHODS: Data were collected from 929 patients with NHL and 3716 healthy subjects, who were matched 1:4 for age, sex, income, and region of residence, from the Korean Health Insurance Review and Assessment Service-National Sample Cohort. The diagnoses of NHL and HBV/HCV infection were based on the International Classification of Diseases (version 10) codes. Conditional logistic regression models were used to assess odds ratios (ORs) for NHL with respect to HBV or HCV with adjustment for the Charlson comorbidity index.
RESULTS: HBV and HCV rates were higher in the NHL group (3.3% and 1.3%, respectively) than in the control group (0.9% and 0.3%, respectively; P < .001 for each). The adjusted OR of hepatitis infection in patients with NHL were 3.25 (95% confidence interval [CI] = 1.99-5.31) for HBV and 3.36 (95% CI = 1.51-7.46) for HCV (P < .001 for each). Subgroups categorized by age (<55 vs ≥55 years) or sex showed significantly higher adjusted ORs of HBV for NHL. Moreover, patients with NHL ≥ 55 years of age or those who were female showed significantly higher adjusted ORs of HCV; those <55 years or who were male also tended to have higher ORs of HCV.
CONCLUSION: Infection with either HBV or HCV is associated with NHL in Koreans.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidemiology; hepatitis B virus; hepatitis C virus; non-Hodgkin lymphoma

Mesh:

Year:  2019        PMID: 31825111     DOI: 10.1002/jmv.25653

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

Review 1.  Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.

Authors:  Iman Ibrahim Salama; Hala M Raslan; Ghada A Abdel-Latif; Somaia I Salama; Samia M Sami; Fatma A Shaaban; Aida M Abdelmohsen; Walaa A Fouad
Journal:  World J Hepatol       Date:  2022-06-27

2.  Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study.

Authors:  Yung-Rung Lai; Ya-Lan Chang; Chiu-Hsiang Lee; Tung-Han Tsai; Kuang-Hua Huang; Chien-Ying Lee
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

3.  Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017.

Authors:  Haifeng Sun; Li Xue; Yahuan Guo; Jianqiang Du; Kejun Nan; Ming Li
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

4.  Hepatitis B virus infection specially increases risk of liver metastasis in breast cancer patients: a propensity-matched analysis.

Authors:  Ping Yu; Peng Liu; Na Li; Xinhua Xie; Hailin Tang; Jiali Wu; Yanan Kong; Xiaoming Xie; Feng Ye
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.